[row][third_paragraph]
[/third_paragraph][paragraph_right]
SDRI 2017 conference
3-5 April 2017, Brisbane, Australia
With a host of global leaders and advocates from the field of drug-resistant infections, SDRI 2017 promises to be a game-changing conference for all involved in infectious disease and antimicrobial resistance.
Don’t miss out on your chance to grow your network. Registrations are still open!
[/paragraph_right][/row]
[row][paragraph_left]
WHO priority pathogens list for R&D of new antibiotics
On 27 February 2017, The World Health Organization (WHO) published its first ever list of antibiotic-resistant “priority pathogens” – a catalogue of 12 families of bacteria that pose the greatest threat to human health.
CO-ADD tests compounds against five of the top pathogens listed by WHO, including the three most critical: Escherichia coli, Klebsiella pneumoniae, Acinetobacter baumannii, Pseudomonas aeruginosa, and Staphylococcus aureus.
[/paragraph_left][third_paragraph]
[/third_paragraph][/row]
[row][third_paragraph]
[/third_paragraph][paragraph_right]
CATCH: award-winning short film on antibiotic resistance
New film CATCH is set in a possible near future where antibiotics can no longer treat infections and the world is on the verge of a global pandemic.
CATCH is currently appearing in festivals and will be publicly available online from September 2017.
[/paragraph_right][/row]
[row][paragraph_left]
Polishing the tarnished silver bullet: the quest for new antibiotics
CO-ADD researchers have recently published a Review Article in Essays in Biochemisty examining the different strategies being applied to discover new antibiotics.
The review is highlighted in the Biochemical Society and Portland Press media release out today: How to solve a problem like antibiotic resistance?
[/paragraph_left][third_paragraph]
[/third_paragraph][/row]